Is PRAX or PRLD more undervalued in 2026?

CirclFi compares Praxis Precision Medicines, Inc (PRAX) and Prelude Therapeutics Incorporat (PRLD) using 13 institutional-grade valuation models. PRAX has a Quality of Company score of 5.6/10 while PRLD scores 5.9/10.

Which is a better buy — PRAX or PRLD?

Compare intrinsic values from 13 independent models against current market prices. CirclFi also calculates Value Trap scores. This is not financial advice — conduct your own analysis.

How do PRAX and PRLD valuations compare?

PRAX at $352.63 and PRLD at $3.93 are compared across Bayesian DCF, EPV, EROIC Spread, First Chicago, Markov DDM, and 8 additional models.

PRAX vs PRLD Valuation Comparison 2026 — Intrinsic Value Analysis

PRAX

Biotechnology

Praxis Precision Medicines, Inc

Quality

5.6

out of 10

Value Trap

SAFE

Price

$352.63

Last close

Models

12/13

Active

PRLD

Biotechnology

Prelude Therapeutics Incorporat

Quality

5.9

out of 10

Value Trap

SAFE

Price

$3.93

Last close

Models

9/13

Active

Model-by-Model Comparison

Model	Type	PRAX Fair Value	PRAX Upside	PRLD Fair Value	PRLD Upside
Bayesian DCF	Intrinsic	$116.77	-66.9%	$1.12	-71.6%
Earnings Power Value	Intrinsic	$151.65	-56.0%	—	—
EROIC Spread	Intrinsic	$•••.••	••.•%	$•••.••	••.•%
First Chicago	Scenario	$•••.••	••.•%	$•••.••	••.•%
Markov DDM	Intrinsic	$•••.••	••.•%	$•••.••	••.•%
ML-RIV	Intrinsic	$•••.••	••.•%	$•••.••	••.•%
Dynamic NAV	Asset-Based	$45.59	-87.1%	$1.75	-55.5%
PWERM	Option-Based	$•••.••	••.•%	$•••.••	••.•%
Regime Cross-Sectional	Relative	$•••.••	••.•%	$•••.••	••.•%
Sentiment SOTP	Hybrid	$•••.••	••.•%	$•••.••	••.•%
CUCE Ensemble	Ensemble	$•••.••	••.•%	$•••.••	••.•%
FTNN Topology	Relative	$•••.••	••.•%	$•••.••	••.•%

🔒

Unlock Full 13-Model Comparison

Access all valuation models for PRAX vs PRLD — including EROIC Spread, First Chicago, Markov DDM, PWERM, and 7 more.

Access Full Analysis — From $27/mo →

PRAX vs PRLD — Which Stock Is More Undervalued?

PRLD scores higher with a 5.9/10 quality rating vs PRAX's 5.6/10. Both stocks are analyzed daily using SEC EDGAR filings across 13 independent models.

Comparing Praxis Precision Medicines, Inc (PRAX) and Prelude Therapeutics Incorporat (PRLD) across 13 institutional-grade valuation models reveals how each company's intrinsic value stacks up against its market price. CirclFi's engine processes SEC EDGAR 10-K and 10-Q filings, FRED macroeconomic data, and GDELT news sentiment to generate independent fair value estimates daily.

PRAX currently trades at $352.63 with a QOC of 5.6/10, while PRLD trades at $3.93 with a QOC of 5.9/10.

Both companies are analyzed with models spanning intrinsic (Bayesian DCF, EPV), scenario-based (First Chicago), regime-switching (Markov DDM, RCMH-DCF), machine learning (ML-RIV, FTNN Topology), and ensemble methods (CUCE).